We are live on
!
Find out more
SC
Salzman & Co Portfolio holdings
AUM
$29.7M
1-Year Est. Return
12.12%
This Fund
S&P 500
This Quarter
Est. Return
-10.12%
1 Year Est. Return
-12.12%
3 Year Est. Return
-15.72%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.7M
AUM Growth
–
Cap. Flow
+$22M
Cap. Flow
% of AUM
101.66%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
3
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$10.2M |
| 2 |
Cigna
CI
|
+$8.1M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$3.72M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 83.46% |
| 2 | Communication Services | 16.54% |
Similar funds
BIM
QCMA
GP
AIM
MF
SCM
OI
CC
Salzman & Co's Q2 2016 Portfolio in Review
Q2 2016 is the first quarter with a 13F filing on record for Salzman & Co, which disclosed 3 positions worth $21.7M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Allergan plc: 44,274 shares worth $10.2M.
By sector, the portfolio is most concentrated in Healthcare at 83% of assets, followed by Communication Services.
- Salzman & Co's largest Q2 2016 buy was Allergan plc: 44,274 shares worth $10.2M.
- Salzman & Co's ten largest holdings make up 100% of its $21.7M portfolio in Q2 2016.
- Salzman & Co disclosed 3 positions in Q2 2016, its first 13F filing on record.
Based on Salzman & Co's 13F filing for Q2 2016, filed 15 Aug 2016.